Cargando…

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab

PURPOSE: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab. OBSERVATIONS: We chronicle a case of severe generalized myasthenia gravis including myasthenia masquerading as a par...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidmayer, Sara L., Gallagher, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498161/
https://www.ncbi.nlm.nih.gov/pubmed/37711751
http://dx.doi.org/10.1016/j.ajoc.2023.101925
Descripción
Sumario:PURPOSE: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab. OBSERVATIONS: We chronicle a case of severe generalized myasthenia gravis including myasthenia masquerading as a partial cranial nerve 3 palsy, refractory to pyridostigmine, mycophenolate, prednisone, intravenous immunoglobulin and plasma exchange but responsive to eculizumab. CONCLUSIONS AND IMPORTANCE: This case demonstrates ocular and generalized myasthenia gravis refractory to several other therapies but amenable to eculizumab infusions, suggesting this medication may be of significant value in these difficult cases, and should be further explored for refractory ocular myasthenia gravis.